Encephalopathy with amyloid angiopathy and numerous amyloid plaques with low levels of CSF Aβ140/Aβ142

Amyloid

Volumn 19, Issue 4, 2012, Pages 186-190

  Ikeda, Masaki ^a   Hirayanagi, Kimitoshi ^a   Arai, Motonobu ^a   Kakuda, Satoko ^a   Makioka, Kouki ^a   Furuta, Natsumi ^a   Takai, Eriko ^a   Kasahara, Hiroo ^a   Tsukagoshi, Setsuki ^a,b   Fujita, Yukio ^a   Amari, Masakuni ^b   Takatama, Masamitsu ^b   Nakazato, Yoichi ^a   Okamoto, Koichi ^a  

^a GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b GERIATRICS RESEARCH INSTITUTE AND HOSPITAL   (Japan)

Author keywords

A (amyloid beta protein); A cerebral amyloid angiopathy (CAA); Alzheimer's disease (AD); CSF (cerebral spinal fluid); Encephalopathy

Indexed keywords

AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; APOLIPOPROTEIN E; BETAMETHASONE; HUMAN IMMUNOGLOBULIN; METHYLPREDNISOLONE; PREDNISOLONE;

ADULT; AMNESIA; AMYLOID PLAQUE; ARTICLE; ASPIRATION PNEUMONIA; BRAIN ATROPHY; BRAIN BIOPSY; BRAIN DISEASE; CASE REPORT; CEREBROSPINAL FLUID; CONSCIOUSNESS DISORDER; CORTICOSTEROID THERAPY; DETERIORATION; DRUG PULSE THERAPY; DYSPHAGIA; GENETIC ANALYSIS; HEADACHE; HOMONYMOUS HEMIANOPIA; HOMOZYGOSITY; HUMAN; JAPANESE; MALE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCIPITAL LOBE; PHOTOPHOBIA; PRIORITY JOURNAL; RECURRENT DISEASE; TEMPORAL LOBE; VASCULAR AMYLOIDOSIS;

AMYLOID BETA-PEPTIDES; APOLIPOPROTEINS E; BIOPSY; BRAIN DISEASES, METABOLIC; CEREBRAL AMYLOID ANGIOPATHY; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; OCCIPITAL LOBE; PEPTIDE FRAGMENTS; PLAQUE, AMYLOID; TEMPORAL LOBE;

EID: 84868338945     PISSN: 13506129     EISSN: 17442818     Source Type: Journal    
DOI: 10.3109/13506129.2012.725113     Document Type: Article

References (27)

1. Gilles C, Brucher JM, Khoubesserian P, Vanderhaeghen JJ. Cerebral amyloid angiopathy as a cause of multiple intracerebral hemorrhages. Neurology 1984;34:730-735. (Pubitemid 14107069)
2. Greenberg SM. Cerebral amyloid angiopathy: prospects for clinical diagnosis and treatment. Neurology 1998;51:690-694. (Pubitemid 28449244)
3. Osumi AK, Tien RD, Felsberg GJ, Rosenbloom M. Cerebral amyloid angiopathy presenting as a brain mass. Am J Neuroradiol 1995;16:911-915.
4. Kinnecom C, Lev MH, Wendell L, Smith EE, Rosand J, Frosch MP, Greenberg SM. Course of cerebral amyloid angiopathy-related inflammation. Neurology 2007;68:1411-1416. (Pubitemid 46661556)
5. Eng JA, Frosch MP, Choi K, Rebeck GW, Greenberg SM. Clinical manifestations of cerebral amyloid angiopathy-related inflammation. Ann Neurol 2004;55:250-256. (Pubitemid 38167002)
6. Scolding NJ, Joseph F, Kirby PA, Mazanti I, Gray F, Mikol J, Ellison D, et al. Abeta-related angiitis: primary angiitis of the central nervous system associated with cerebral amyloid angiopathy. Brain 2005;128:500-515. (Pubitemid 40380186)
7. Hoshi K, Yoshida K, Nakamura A, Tada T, Tamaoka A, Ikeda S. Cessation of cerebral hemorrhage recurrence associated with corticosteroid treatment in a patient with cerebral amyloid angiopathy. Amyloid 2000;7:284-288.
8. Machida K, Tsuchiya-Suzuki A, Sano K, Arima K, Saito Y, Kametani F, Ikeda S. Postmortem findings in a patient with cerebral amyloid angiopathy actively treated with corticosteroid. Amyloid 2012;19:47-52.
9. Gilbert JJ, Vinters HV. Cerebral amyloid angiopathy: incidence and complications in the aging brain. I. Cerebral hemorrhage. Stroke 1983;14:915-923. (Pubitemid 14205242)
10. Greenberg SM, Vonsattel JP, Stakes JW, Gruber M, Finklestein SP. The clinical spectrum of cerebral amyloid angiopathy: presentations without lobar hemorrhage. Neurology 1993;43:2073-2079. (Pubitemid 23318883)
11. Aisen PS. The potential of anti-inflammatory drugs for the treatment of Alzheimer's disease. Lancet Neurol 2002;1:279-284. (Pubitemid 37159171)
12. Ikeda M, Sharma V, Sumi SM, Rogaeva EA, Poorkaj P, Sherrington R, Nee L, et al. The clinical phenotype of two missense mutations in the presenilin I gene in Japanese patients. Ann Neurol 1996;40:912-917. (Pubitemid 27044610)
13. Wenham PR, Price WH, Blandell G. Apolipoprotein E genotyping by one-stage PCR. Lancet 1991;337:1158-1159.
14. Mucllan M, Crawford F, Axelman K, Houlden H, Lilius L, Winbald B, Lannfelt L. A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of beta-amyloid. Nat Genet 1992;1:345-347.
15. Goate A, Chartier-Harlin MC, Mullan M, Brown J, Crawford F, Fidani L, Giuffra L, et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 1991;349:704-706. (Pubitemid 21912142)
16. Ikeda M, Mizushima K, Fujita Y, Watanabe M, Sasaki A, Makioka K, Enoki M, et al. Familial amyloid polyneuropathy (Finnish type) in a Japanese family: Clinical features and immunocytochemical studies. J Neurol Sci 2007;252:4-8. (Pubitemid 44909180)
17. Ikeda M, Shoji M, Kawarai T, Kawarabayashi T, Matsubara E, Murakami T, Sasaki A, et al. Accumulation of filamentous tau in the cerebral cortex of human tau R406W transgenic mice. Am J Pathol 2005;166:521-531. (Pubitemid 40189048)
18. Fukumoto H, Tokuda T, Kasai T, Ishigami N, Hidaka H, Kondo M, Allsop D, Nakagawa M. High-molecular-weight beta-amyloid oligomers are elevated in cerebrospinal fluid of Alzheimer patients. FASEB J 2010;24:2716-2726.
19. Kasuga K, Tokutake T, Ishikawa A, Uchiyama T, Tokuda T, Onodera O, Nishizawa M, Ikeuchi T. Differential levels of alpha-synuclein, beta-amyloid42 and tau in CSF between patients with dementia with Lewy bodies and Alzheimer's disease. J Neurol Neurosurg Psychiatr 2010;81:608-610.
20. Campbell DM, Bruins S, Vogel H, Shuer LM, Wijman CA. Intracerebral hemorrhage caused by cerebral amyloid angiopathy in a 53-year-old man. J Neurol 2008;255:597-598.
21. Biffi A, Greenberg SM. Cerebral amyloid angiopathy: a systematic review. J Clin Neurol 2011;7:1-9.
22. Suzuki N, Iwatsubo T, Odaka A, Ishibashi Y, Kitada C, Ihara Y. High tissue content of soluble beta 1-40 is linked to cerebral amyloid angiopathy. Am J Pathol 1994;145:452-460. (Pubitemid 24245845)
23. Renard D, Castelnovo G, Wacongne A, Le Floch A, Thouvenot E, Mas J, Gabelle A, et al. Interest of CSF biomarker analysis in possible cerebral amyloidangiopathy cases defined by the modified Boston criteria. J Neurol 2012 (In Press).
24. Previti ML, Zhang W, Van Nostrand WE. Dexamethasone diminishes the pro-inflammatory and cytotoxic effects of amyloid beta-protein in cerebrovascular smooth muscle cells. J Neuroinflammation 2006;3:18.
25. Kloppenborg RP, Richard E, Sprengers ME, Troost D, Eikelenboom P, Nederkoorn PJ. Steroid responsive encephalopathy in cerebral amyloid angiopathy: a case report and review of evidence for immunosuppressive treatment. J Neuroinflammation 2010;7:18.
26. Englund H, Degerman Gunnarsson M, Brundin RM, Hedlund M, Kilander L, Lannfelt L, Pettersson FE. Oligomerization partially explains the lowering of Abeta42 in Alzheimer's disease cerebrospinal fluid. Neurodegener Dis 2009;6:139-147.
27. Sperling RA, Jack CR Jr, Black SE, Frosch MP, Greenberg SM, Hyman BT, Scheltens P, et al. Amyloid-related imaging abnormalities in amyloidmodifying therapeutic trials: recommendations from the Alzheimer's Association Research Roundtable Workgroup. Alzheimers Dement 2011;7:367-385.